Clinical trial
Study of Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive Population
NCT07652567 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Antihypertensive Treatment and Cardiovascular Risk in Chinese Prehypertensive Population
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2007
- Completion date
- April 30, 2026
- Enrollment
- 690 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
high-normal blood pressure